CBIC CIC Actual Questions

The CBIC Certified Infection Control Exam Study Guide (6th edition) explains that an interpretive surveillance report goes beyond simply presenting raw data. Its primary purpose is to translate surveillance findings into meaningful, actionable information that can be understood and used by the intended audience, such as frontline staff, clinical leaders, executive leadership, or quality committees.

Interpretive reports contextualize infection data by explaining trends, comparisons, implications, and recommended actions. This may include highlighting increases or decreases in infection rates, identifying areas of concern, interpreting statistical significance, and linking findings to prevention strategies. The format, level of detail, and language are tailored to the audience’s role and decision-making responsibilities. For example, senior leadership may need high-level summaries and risk implications, while unit-level staff benefit from detailed, practice-focused feedback.

Option A describes a mission statement, not a surveillance report. Option B refers to program evaluation logistics rather than interpretation of findings. Option C outlines quality improvement processes but does not describe how surveillance data are communicated.

For the CIC® exam, it is essential to recognize that interpretive surveillance reporting focuses on meaningful communication, not just data display. Providing findings in a manner designed for the intended audience ensures surveillance data drive prevention actions, accountability, and performance improvement—making option D the best answer.

The CBIC Certified Infection Control Exam Study Guide (6th edition) emphasizes that measles is a reportable, airborne disease, but actions such as public health notification and contact tracing should occur after appropriate clinical and laboratory confirmation is initiated, unless there is a clear epidemiologic link or high clinical suspicion.

In this scenario, the diagnosis was made solely on the basis of rash, which is insufficient to confirm measles. Many viral illnesses can present with rash, and misclassification can lead to unnecessary alarm, resource use, and disruption. Therefore, the next appropriate step for the infection preventionist is to discuss necessary diagnostic testing with the provider, such as measles-specific IgM serology and PCR testing, to confirm or rule out measles.

Options A and B are premature. Public health notification and contact tracing are essential after measles is suspected and testing is initiated or confirmed, but they should not precede diagnostic clarification when the diagnosis is uncertain. Option D may support clinical assessment but does not replace the need for laboratory confirmation.

The Study Guide highlights that infection preventionists must balance rapid response with diagnostic accuracy. Ensuring appropriate testing is initiated first allows subsequent infection control actions—such as airborne exposure assessment and public health reporting—to be targeted, evidence-based, and defensible.

For the CIC® exam, this question tests understanding of sequencing infection prevention actions, reinforcing that confirmation and testing discussion is the critical next step before escalation.

Reviewing compliance with VAP prevention bundles (e.g., head-of-bed elevation, oral care, sedation breaks) is the first step in outbreak control​.

Preemptive antibiotics (B) are not recommended due to antibiotic resistance risks.

Negative pressure rooms (C) are not required for VAP.

Ventilator circuit cultures (D) do not guide patient management.

CBIC Infection Control References:

APIC Text, "VAP Prevention Measures," Chapter 11​.

Chlorhexidine-impregnated dressings reduce central line-associated bloodstream infections (CLABSI) by preventing bacterial colonization​.

Routine catheter replacement (A) increases insertion risks without reducing infections.

Daily blood cultures (C) are unnecessary and lead to false positives.

Povidone-iodine (D) is less effective than chlorhexidine for skin antisepsis.

CBIC Infection Control References:

APIC Text, "CLABSI Prevention Measures," Chapter 10​.